Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

55.75
Delayed Data
As of Feb 12
 +1.67 / +3.09%
Today’s Change
53.78
Today|||52-Week Range
72.31
-15.07%
Year-to-Date

Today’s Trading

Previous close54.08
Today’s open54.16
Day’s range53.85 - 56.06
Volume7,577,191
Average volume (3 months)5,841,942
Market cap$56.9B
Dividend yield2.45%
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+139.61%
Earnings growth (this year)+6.79%
Earnings growth (next 5 years)+5.99%
Revenue growth (last year)-0.47%
P/E ratio27.0
Price/Sales2.43
Price/Book2.04

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc0.000.00%
BGNEBeiGene Ltd-0.12-0.50%
DNAIProNAi Therapeutics ...+0.11+1.75%
OASMOasmia Pharmaceutica...-0.09-2.28%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateApril 28, 2016
EPS forecast (this quarter)$1.18
Annual revenue (last year)$20.3B
Annual profit (last year)$3.1B
Net profit margin15.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts

Partner Offers